A detailed history of Affinity Asset Advisors, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 351,587 shares of ROIV stock, worth $4.11 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
351,587
Previous 500,000 29.68%
Holding current value
$4.11 Million
Previous $5.27 Million 29.49%
% of portfolio
0.51%
Previous 0.76%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$10.36 - $11.74 $1.54 Million - $1.74 Million
-148,413 Reduced 29.68%
351,587 $3.72 Million
Q4 2023

Feb 13, 2024

BUY
$8.38 - $11.58 $2.93 Million - $4.05 Million
350,000 Added 233.33%
500,000 $5.62 Million
Q3 2023

Nov 14, 2023

BUY
$9.76 - $13.19 $1.46 Million - $1.98 Million
150,000 New
150,000 $1.75 Million
Q1 2023

May 15, 2023

BUY
$6.92 - $9.98 $692,000 - $998,000
100,000 New
100,000 $738,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.23B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Affinity Asset Advisors, LLC Portfolio

Follow Affinity Asset Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.